RAPILIF 4MG CAPSULE
Selected Pack Size:10
(₹19.67 per unit)
In Stock
(₹19.68 per unit)
In Stock
₹161.6*
MRP ₹179.5
10% off
₹152.5*
MRP ₹179.5
15% CB
₹27 cashback(15%)
Free Delivery
With Circle membership
(Inclusive of all Taxes)
This offer price is valid on orders above ₹800. Apply coupon PHARMA10/PHARMA18 (excluding restricted items)
Provide Delivery Location
RAPILIF 4MG CAPSULE belongs to the group of medicines called 'alpha-blockers' used to treat the symptoms of an enlarged prostate gland (benign prostatic hyperplasia - BPH) in men. Benign prostatic hyperplasia (BPH) is a condition in which there is an enlargement of the prostate gland due to the multiplication of the cells mostly in men above 50 years of age. The growth of the prostate gland is non-cancerous in nature.
RAPILIF 4MG CAPSULE contains ‘Silodosin’ that works by blocking the receptors (alpha 1) located in the prostate, bladder and urethra (urine pipe), thereby relaxes the muscles of the bladder and prostate gland. This help in relieving the symptoms of benign prostatic hyperplasia and makes it easier to pass water, thereby increasing urine output and flow.
You are advised to take RAPILIF 4MG CAPSULE for as long as your doctor has prescribed it for you, depending on your medical condition. In some cases, RAPILIF 4MG CAPSULE may cause common side-effects such as ejaculation disorders (orgasm with reduced or no sperm), dizziness, diarrhoea, stuffy nose (nasal congestion), and orthostatic hypotension (sudden lowering in blood pressure leading to dizziness on standing). Most of these side effects do not require medical attention and will resolve gradually over time. However, you are advised to talk to your doctor if you experience these side effects persistently.
Inform your doctor if you have low blood pressure, liver or kidney disease. RAPILIF 4MG CAPSULE is intended for use in men only; women should not take RAPILIF 4MG CAPSULE, especially pregnant or breastfeeding women. RAPILIF 4MG CAPSULE should not be given to children as safety and efficacy have not been established. RAPILIF 4MG CAPSULE may cause dizziness, so drive with caution. Avoid or limit alcohol consumption along with RAPILIF 4MG CAPSULE as it could lead to increased dizziness. Inform your doctor about your health condition and medications to rule out any side-effects.
RAPILIF 4MG CAPSULE belongs to the group of medicines called alpha-blockers used to treat the symptoms of an enlarged prostate (benign prostatic hyperplasia) mostly in men above 50 years of age. RAPILIF 4MG CAPSULE works by blocking the receptors (alpha 1) located in the prostate, bladder and urethra (urine pipe), thereby relaxes the muscles of the bladder and prostate gland. This help in relieving the symptoms of benign prostatic hyperplasia and makes it easier to pass water, thereby increasing urine output and flow.
Do not take RAPILIF 4MG CAPSULE if you are allergic to Silodosin, any alpha 1 blockers or any of the components in RAPILIF 4MG CAPSULE. Inform your doctor if you have low blood pressure, liver or kidney disease. Talk to your doctor before taking RAPILIF 4MG CAPSULE if you are undergoing eye surgery (cataract surgery) as cases of intraoperative floppy iris syndrome (IFIS) have been found in some cases. RAPILIF 4MG CAPSULE is intended for use in men only; women should not take RAPILIF 4MG CAPSULE, especially pregnant or breastfeeding women. RAPILIF 4MG CAPSULE should not be given to children as safety and efficacy have not been established. RAPILIF 4MG CAPSULE may cause dizziness, so drive only if you are alert. Avoid or limit alcohol consumption along with RAPILIF 4MG CAPSULE as it could lead to increased dizziness.
Drug-Drug Interactions: RAPILIF 4MG CAPSULE may interact with antifungals (itraconazole, ketoconazole), blood pressure-lowering pills (verapamil, metoprolol, diltiazem), antiviral (ritonavir), immune-suppressing drugs (cyclosporine), antibiotics (clarithromycin, erythromycin), and erectile dysfunction pills (tadalafil, sildenafil).
Drug-Food Interactions: Avoid or limit alcohol consumption along with RAPILIF 4MG CAPSULE as it could lead to increased dizziness.
Drug-Disease Interactions: Inform your doctor if you have hypotension (low blood pressure), liver impairment and severe kidney impairment.
If you have had cataract surgery, let your doctor know before taking RAPILIF 4MG CAPSULE as it may affect the pupil of the eye during cataract surgery. In some cases, intraoperative floppy iris syndrome (IFIS) has been found.
Benign prostatic hyperplasia (BPH): The prostate is a small, muscular gland in the male reproductive system which surrounds the urethra. Benign prostatic hyperplasia is a condition in which there is an enlargement of the prostate gland which occurs due to the multiplication of the cells. This causes the prostate gland to swell, which leads to the squeezing of the urethra and limits the urine flow. The symptoms of benign prostatic hyperplasia include painful urination, difficulty in urination, excess urination, incomplete urination, leakage of urine, dribbling at the end of the urinary stream, and urgency in urination. An enlarged prostate is a normal condition in older men due to changes in male sex hormones.
Country of origin
Manufacturer/Marketer address
Customers Also Bought
Alcohol
Caution
You are recommended to avoid or limit alcohol consumption while taking RAPILIF 4MG CAPSULE as it may cause increased dizziness.
Pregnancy
Unsafe
RAPILIF 4MG CAPSULE is intended for use in men only; women should not take RAPILIF 4MG CAPSULE, especially pregnant women.
Breast Feeding
Unsafe
RAPILIF 4MG CAPSULE is intended for use in men only; women should not take RAPILIF 4MG CAPSULE, especially breastfeeding women.
Driving
Unsafe
RAPILIF 4MG CAPSULE may cause dizziness. Do not drive or operate heavy machinery if you experience dizziness.
Liver
Unsafe
RAPILIF 4MG CAPSULE should not be used if you have severe liver impairment. Please consult your doctor if you have a liver impairment or any concerns regarding this.
Kidney
Caution
Dose adjustment may be necessary. Please consult your doctor if you have kidney impairment or any concerns regarding this.
Children
Unsafe
RAPILIF 4MG CAPSULE should not be given to children as the safety and efficacy have not been established.
Product Substitutes